跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 33 条关于
“KLK1”
全部
33
临床试验
8
药物
16
机构
0
资讯
9
去年
DiaMedica Receives SAHPRA Approval to Commence Phase II Preeclampsia Trial with DM199
去年
DiaMedica Therapeutics Appoints Julie Krop as Chief Medical Officer to Advance DM199 Development
去年
DiaMedica Therapeutics Secures $30.1 Million to Advance DM199 for Preeclampsia and Fetal Growth Restriction
去年
DiaMedica's DM199 Shows Promising Blood Pressure Reduction in Phase 2 Preeclampsia Trial
去年
Chromophobe Renal Cell Carcinoma Shows Immune-Cold Environment and Poor Response to Checkpoint Inhibitors
10个月前
Cardiff Oncology Reports Positive Phase 2 Data for PLK1 Inhibitor Onvansertib in RAS-Mutated Colorectal Cancer
12个月前
Triveni Bio Initiates Phase 2 Trial of Novel Anti-KLK5/7 Antibody TRIV-509 for Atopic Dermatitis
9个月前
Cardiff Oncology's PLK1 Inhibitor Onvansertib Shows Promise in CMML Trial and Advances Toward Phase III in Colorectal Cancer
去年
Juri Biosciences Secures Global Rights to KLK2-Targeted T-Cell Engager for Metastatic Prostate Cancer in $210M Deal